Products found to contain undeclared medicines
|
| |
| The United States: Je Dois L’avoir Boutique issues voluntary nationwide recall of 365 Skinny High Intensity and 365 Skinny Emergency Boutique due to the presence of sibutramine |
| |
The US Food and Drug Administration (FDA) announces that Je Dois L’avoir Boutique is voluntarily recalling all of the 365 Skinny High Intensity Pills and 365 Skinny Emergency Boutique, 30 day capsules supply to the retail/consumer level. The 365 Skinny High Intensity Pills and 365 Skinny Emergency Boutique have been found to contain sibutramine which is a controlled substance and poses significant health risks to consumers.
The 365 Skinny High Intensity Pills and 365 Skinny Emergency Boutique potentially can cause serious health risks such as seizures, tachycardia, palpitations, heart attacks and allergic reactions. Risks associated with these products are more likely with people who have high blood pressure, thyroid disease, men or woman over 65 or children under 16 years old. Je Dois L’avoir Boutique has not received any reports of adverse events related to this recall.
All lots and expiration dates of any of these products are being recalled.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/je-dois-lavoir-boutique-issues-voluntary-nationwide-recall-365-skinny-high-intensity-and-365-skinny
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by FDA, and was posted on the Drug Office website on 2 Jul 2021.
Ends/Tuesday, Aug 3, 2021
Issued at HKT 14:00
|
| |
|
